Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2022-04-11 00:00:00 ET · period of report 2022-04-07 · accession 0001883850-22-000040 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-04-11 | 2022-04-07+ | REGN | Landry Robert E | EVP Fin CFO | M - OptEx | $388.46 | +9,500 | 32.2K | +42% | +$3.69M |
| DM | 2022-04-11 | 2022-04-07+ | REGN | Landry Robert E | EVP Fin CFO | F - Tax | $732.98 | -7,313 | 30.6K | -19% | -$5.36M |
| DM | 2022-04-11 | 2022-04-08+ | REGN | Landry Robert E | EVP Fin CFO | S - Sale+OE | $734.61 | -2,187 | 28.7K | -7% | -$1.61M |
| DM | 2022-04-11 | 2022-04-07+ | REGN | Landry Robert E | EVP Fin CFO | M - OptEx | $0.00 | -9,500 | 2,000 | -83% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-07 | M | A | 1,500 | $399.66 | 30,244 | D | — | — | |
| 2 | Common | Common Stock | 2022-04-07 | F | D | 1,175 | $716.09 | 29,069 | D | — | — | |
| 3 | Common | Common Stock | 2022-04-08 | S | D | 16 | $724.33 | 29,053 | D | — | — | |
| 4 | Common | Common Stock | 2022-04-08 | S | D | 30 | $728.77 | 29,023 | D | — | — | |
| 5 | Common | Common Stock | 2022-04-08 | S | D | 16 | $729.67 | 29,007 | D | — | — | |
| 6 | Common | Common Stock | 2022-04-08 | S | D | 44 | $733.38 | 28,963 | D | — | — | (F2) Represents volume-weighted average price of sales of 44 shares of Company stock on April 8, 2022 at prices ranging from $733.28 to $733.44. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 8, 2022 at each separate price. |
| 7 | Common | Common Stock | 2022-04-08 | S | D | 43 | $735.12 | 28,920 | D | — | — | (F3) Represents volume-weighted average price of sales of 43 shares of Company stock on April 8, 2022 at prices ranging from $735.06 to $735.23. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 8, 2022 at each separate price. |
| 8 | Common | Common Stock | 2022-04-08 | S | D | 29 | $739.02 | 28,891 | D | — | — | |
| 9 | Common | Common Stock | 2022-04-08 | S | D | 28 | $740.98 | 28,863 | D | — | — | |
| 10 | Common | Common Stock | 2022-04-08 | S | D | 32 | $743.71 | 28,831 | D | — | — | (F4) Represents volume-weighted average price of sales of 32 shares of Company stock on April 8, 2022 at prices ranging from $743.48 to $743.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 8, 2022 at each separate price. |
| 11 | Common | Common Stock | 2022-04-08 | S | D | 56 | $744.52 | 28,775 | D | — | — | |
| 12 | Common | Common Stock | 2022-04-08 | S | D | 31 | $745.27 | 28,744 | D | — | — | |
| 13 | Common | Common Stock | 2022-04-08 | M | A | 6,000 | $381.92 | 34,744 | D | — | — | |
| 14 | Common | Common Stock | 2022-04-08 | F | D | 4,586 | $736.21 | 30,158 | D | — | — | |
| 15 | Common | Common Stock | 2022-04-08 | M | A | 2,000 | $399.66 | 32,158 | D | — | — | |
| 16 | Common | Common Stock | 2022-04-08 | F | D | 1,552 | $736.21 | 30,606 | D | — | — | |
| 17 | Common | Common Stock | 2022-04-11 | S | D | 74 | $729.76 | 30,532 | D | — | — | (F5) Represents volume-weighted average price of sales of 74 shares of Company stock on April 11, 2022 at prices ranging from $729.63 to $729.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 11, 2022 at each separate price. |
| 18 | Common | Common Stock | 2022-04-11 | S | D | 37 | $731.60 | 30,495 | D | — | — | (F6) Represents volume-weighted average price of sales of 37 shares of Company stock on April 11, 2022 at prices ranging from $731.57 to $731.64. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 11, 2022 at each separate price. |
| 19 | Common | Common Stock | 2022-04-11 | S | D | 22 | $732.56 | 30,473 | D | — | — | (F7) Represents volume-weighted average price of sales of 22 shares of Company stock on April 11, 2022 at prices ranging from $732.00 to $732.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 11, 2022 at each separate price. |
| 20 | Common | Common Stock | 2022-04-11 | S | D | 1,226 | $733.52 | 29,247 | D | — | — | (F8) Represents volume-weighted average price of sales of 1,226 shares of Company stock on April 11, 2022 at prices ranging from $733.40 to $733.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 11, 2022 at each separate price. |
| 21 | Common | Common Stock | 2022-04-11 | S | D | 75 | $734.53 | 29,172 | D | — | — | (F9) Represents volume-weighted average price of sales of 75 shares of Company stock on April 11, 2022 at prices ranging from $734.08 to $734.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 11, 2022 at each separate price. |
| 22 | Common | Common Stock | 2022-04-11 | S | D | 149 | $735.36 | 29,023 | D | — | — | (F10) Represents volume-weighted average price of sales of 149 shares of Company stock on April 11, 2022 at prices ranging from $735.02 to $735.58. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 11, 2022 at each separate price. |
| 23 | Common | Common Stock | 2022-04-11 | S | D | 189 | $736.61 | 28,834 | D | — | — | (F11) Represents volume-weighted average price of sales of 189 shares of Company stock on April 11, 2022 at prices ranging from $736.40 to $736.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 11, 2022 at each separate price. |
| 24 | Common | Common Stock | 2022-04-11 | S | D | 22 | $737.89 | 28,812 | D | — | — | |
| 25 | Common | Common Stock | 2022-04-11 | S | D | 68 | $738.63 | 28,744 | D | — | — | |
| 26 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-04-08 | M | D | 6,000 | $0.00 | 12,800 | D | $381.92 · — to 2026-12-16 | 6,000 Common Stock | (F12) The stock option award vests in four equal annual installments, commencing one year after the date of grant. |
| 27 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-04-08 | M | D | 2,000 | $0.00 | 0 | D | $399.66 · — to 2024-12-16 | 2,000 Common Stock | (F12) The stock option award vests in four equal annual installments, commencing one year after the date of grant. |
| 28 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-04-07 | M | D | 1,500 | $0.00 | 2,000 | D | $399.66 · — to 2024-12-16 | 1,500 Common Stock | (F12) The stock option award vests in four equal annual installments, commencing one year after the date of grant. |